Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Efficacy of WOL071-007 in Atopic Dermatitis Patients [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating safety, tolerability, pharmacokinetics and preliminary efficacy of WOL071-007 in adults with atopic dermatitis; study complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• WOL071-007

Snippet

Sponsor: Dr. August Wolff GmbH & Co. KG Arzneimittel | Conditions: Dermatitis, Atopic | Phase 1 | Status: COMPLETED